Skip Nav Destination
Issues
Journal Name Change
Vol. 1-36 (1978-2013) were published under the journal's former title Onkologie.
Oncology Research and Treatment 2022, Vol. 45, No. 12
Research Article
Stereotactic Radiotherapy for Adrenal Metastases: A Multi-Institutional Review of Patient Characteristics and Outcomes – Turkish Society for Radiation Oncology SBRT Group Study (Trod SBRT 10-004)
Subject Area:
Oncology
Aysenur Elmali; Berna Akkus Yildirim; Mustafa Cengiz; Sezin Yuce Sari; Huseyin C. Onal; Tanju Berber; Aysun Arslantas Erken; Teuta Zoto Mustafayev; Banu Atalar; Ilhami Unal; Nuri Kaydihan; Fazilet Oner Dincbas
Oncol Res Treat (2022) 45 (12): 717–727.
https://doi.org/10.1159/000527052
Breast Cancer Patients Are at Increased Risk of Developing Uterine Serous Cancer: Implications for Counseling – A SEER Analysis
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (12): 728–735.
https://doi.org/10.1159/000525522
Male Breast Cancer: Therapy-Induced Toxicities, Psychological Distress, and Individual Patient Goals during Oncological Inpatient Rehabilitation
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (12): 736–743.
https://doi.org/10.1159/000526704
The Burden of Fear of Cancer Recurrence in Genitourinary Cancers: A Prospective Study (NCT04535921)
Subject Area:
Oncology
Yannic Volz; Johanna Troost; Lennert Eismann; Friedrich Jokisch; Gerald Bastian Schulz; Boris Schlenker; Alexander Kretschmer; Michael Staehler; Stefan Boeck; Raphaela Waidelich; Alexander Buchner; Christian G. Stief; Severin Rodler
Oncol Res Treat (2022) 45 (12): 744–751.
https://doi.org/10.1159/000527161
Review Article
Platinum-Based Chemotherapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: Summary of Evidence and Application in Clinical Practice
Subject Area:
Oncology
Anke Reinacher-Schick; Dirk Arnold; Marino Venerito; Eray Goekkurt; Anna-Lena Kraeft; Thomas Seufferlein
Oncol Res Treat (2022) 45 (12): 752–763.
https://doi.org/10.1159/000527692
Acknowledgement to Reviewers
Acknowledgement to Reviewers
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (12): 764.
https://doi.org/10.1159/000528123
PharmaForum
BTKi: die Entwicklung geht weiter
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (12): 765.
https://doi.org/10.1159/000528304
Pharma News
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (12): 766–768.
https://doi.org/10.1159/000528299
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (12): 769–775.
https://doi.org/10.1159/000528301
Society Bulletins
Society Bulletins
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (12): 776–780.
https://doi.org/10.1159/000528110
Contents
Contents Vol. 45, 2022
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (12): I–X.
https://doi.org/10.1159/000528124
